USPTO serial 88928387
MEDPOINT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GARDNER, DAWNA BERYL
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MEDPOINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Greenville, SC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd M. Ericsson, Esq.
TODD M. ERICSSON, ESQ. THE ERICSSON LAW FIRM, LLC1501 BELLE ISLE AVENUESUITE 110MT PLEASANT, SC 29464Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Consulting services in the field of medical product approval for commercial purposes; Medical personnel recruitment services and consultation related thereto; Business consultation in the field of medical device, biotechnology, and pharmaceuticals, by providing on-site specialty human resource solutions for medical device, biotechnology, and pharmaceutical companies needing to satisfy state, federal and international standards and regulations. Training and educating medical staffs regarding state, federal and international standards and regulations effecting the development, design and sales of medical devices, biotechnologies and pharmaceuticals. Preparing curriculum regarding state, federal and international standards and regulations effecting the development, design and sales of medical devices, biotechnologies and pharmaceuticals. Conducting audits for companies in the medical device, biotechnology, and pharmaceutical industries to ensure organizations stay current with industry best practices in quality assurance, regulatory affairs, and clinical affairs. Developing clinical best-practices and building quality management systems for companies seeking certification under International Organization for Standardization. Working with companies to build agile regulatory affairs programs to address current regulatory requirements and those subsequently promulgated. Working with companies to build effective auditing programs to ensure regulatory compliance, licensing and registration. Developing clinical strategies and protocols for companies in the medical device, biotechnology and pharmaceuticals industries. Recruiting and placing personnel for companies in the medical device, biotechnology and pharmaceuticals industries. Providing companies in the medical device, biotechnology and pharmaceuticals industries with technical problem solving solutions and systems.; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business management consulting, strategic planning and business advisory services provided to medical device, biotechnology, and pharmaceutical industries.; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval | ACTIVE | Jun 9, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 1, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 31, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 30, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2020 | NWAP | NEW APPLICATION ENTERED | — |